Noevir Holdings Co., Ltd.
Fiscal 2024
(October 1, 2023 - September 30, 2024)
November 15, 2024
Noevir Holdings Co., Ltd.
Ikkou Yoshida, Managing Director
Copyright © 2024 Noevir Holdings Co., Ltd. All Rights Reserved.
Company Overview
Noevir Holdings Co., Ltd. Tokyo Stock Exchange, Prime Market Ticker: 4928
Date of Establishment | March 22, 2011 (Noevir Co., Ltd. was founded in April 1964.) |
Paid-in Capital | ¥7,319 million |
Consolidated Subsidiaries | 13 subsidiaries (6 domestic / 7 international) |
Employees | 1,369 (Consolidated) (As of September 30, 2024) |
Number of Shareholders | 20,619 (As of September 30, 2024) |
Outstanding Shares | 34,156 thousand shares |
Market Capitalization | ¥170.612 billion (November 14, 2024 @ ¥4,995) |
Line of Business |
Cosmetics | Pharmaceuticals & Health Food | ||
Copyright © 2024 Noevir Holdings Co., Ltd. All Rights Reserved. |
Apparel
business Aviation- related business
Other
1
1. Results for Fiscal 2024
2. Fiscal 2024 Segment-based Highlights
3. Medium- to Long-term Strategy
4. Forecasts and Initiatives for Fiscal 2025
Copyright © 2024 Noevir Holdings Co., Ltd. All Rights Reserved. | 2 |
Fiscal 2024 Consolidated Results Summary
Sales and profit increased for three consecutive periods
Achieved record-high net income attributable to owners of the parent
Fiscal 2024 | Year-on-year | Planned Company | |
change | target | ||
(vs. forecast target) | |||
Net sales | 63.8 billion yen | +2.0％ | +1.3％ |
Operating income | 11.4 billion yen | +3.6％ | +2.0％ |
Operating income margin | 17.9％ | +0.3pt | +0.1pt |
➢ Factor increasing sales and profits | Operating income margin | |
Self-selection cosmetics performed strongly | 17.9％ | |
Copyright © 2024 Noevir Holdings Co., Ltd. All Rights Reserved. | 3 |
Fiscal 2024 Highlights
Net sales 63.8 billion yen (+2.0% year-on-year), operating income 11.4 billion yen (+3.6%),
ordinary income 11.5 billion yen (+2.6%), net income attributable to owners of the parent 7.9 billion yen (+3.9%)
Year ended September | Year ended September | Year-on-year change | Earning forecast | |||||
30, 2024 | 30, 2023 | |||||||
Millions of yen | Millions of yen | Millions of yen | ％ | Millions of yen | ％ | |||
Net sales | 63,823 | 62,552 | 1,270 | 2.0 | 63,000 | 1.3 | ||
Cost of sales | 20,666 | 19,988 | 678 | 3.4 | ||||
Gross profit | 43,156 | 42,564 | 591 | 1.4 | ||||
SG&A | 31,733 | 31,540 | 193 | 0.6 | ||||
Operating income | 11,423 | 11,024 | 398 | 3.6 | 11,200 | 2.0 | ||
Non-operating income (expenses) | 171 | 271 | (100) | (36.9) | ||||
Ordinary income | 11,594 | 11,295 | 298 | 2.6 | 11,400 | 1.7 | ||
Extraordinary income (losses) | 24 | 2 | 21 | 854.8 | ||||
Income before income taxes | 11,619 | 11,298 | 320 | 2.8 | ||||
Income taxes | 3,648 | 3,625 | 23 | 0.7 | ||||
Net income attributable to owners of the parent | 7,970 | 7,673 | 296 | 3.9 | 7,800 | 2.2 | ||
Cost of sales ratio (%) | 32.4 | 32.0 | ー | 0.4pt | ー | ー | ||
Operating income margin (%) | 17.9 | 17.6 | ー | 0.3pt | 17.8 | 0.1pt | ||
Ordinary income margin (%) | 18.2 | 18.1 | ー | 0.1pt | 18.1 | 0.1pt | ||
Net income attributable to owners of the parent margin | 12.5 | 12.3 | ー | 0.2pt | 12.4 | 0.1pt | ||
SG&A ratio (%) | 49.7 | 50.4 | ー | (0.7pt) | ー | ー | ||
Copyright © 2024 Noevir Holdings Co., Ltd. All Rights Reserved. | 4 |
Net Sales and Operating Income
(Millions of yen)
Net sales | Operating income | 59,252 | 61,143 | 62,552 | 63,823 | |||||
57,828 | ||||||||||
54,473 | 51,841 | 51,272 | ||||||||
49,387 | 51,180 | |||||||||
11,423
7,588 | 7,706 | 9,986 | 11,343 | 11,992 | 8,060 | 8,557 | 10,115 | 11,024 | ||||||||||||||||||
FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
Sales and profit increased for three consecutive periods
Copyright © 2024 Noevir Holdings Co., Ltd. All Rights Reserved. | 5 |
Operating Income Margin
19.6% | 20.2% | 17.9% |
18.3% | 17.6% | ||||
16.7% | |||||
15.5% | 16.5% | ||||
15.4% | 15.1% | ||||
FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
Continued to maintain a high operating income margin in FY2024
Copyright © 2024 Noevir Holdings Co., Ltd. All Rights Reserved. | 6 |
Fiscal 2024 Reasons for Change in Operating Income
+591 | ||||||||||||||
-71 | ||||||||||||||
-82 | -40 | |||||||||||||
11,0240,115 | Increasein gross profit | salestodue increase | Increasein personnel expenses | Increasein A&P | Increasein sundry expenses | |||||||||
FY2023 | Increase in operating income of 398 million yen |
Copyright © 2024 Noevir Holdings Co., Ltd. All Rights Reserved.
(Millions of yen)
Factors increasing profit
Factors decreasing profit
11,0241,423
FY2024
7
Monthly Net Sales in the Cosmetics Segment Year on Year
Fiscal 2024
2022 | 2023 | 2024 |
Oct. | Nov. Dec. Jan. Feb. Mar. Apr. May | Jun. Jul. Aug. Sep. Oct. Nov. Dec. Jan. Feb. Mar. Apr. May Jun. Jul. Aug. Sep. |
Copyright © 2024 Noevir Holdings Co., Ltd. All Rights Reserved. | 8 |
Return on Equity
15.0%
14.1％ | 13.8％ | 14.6％ | 14.6％ |
12.3％ | 12.3％ |
10.7％ |
8.9％ 9.2%
FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
Achieved stable management efficiency and reached a record high
Copyright © 2024 Noevir Holdings Co., Ltd. All Rights Reserved. | 9 |